A Study to Investigate the Pharmacokinetics of Midazolam after Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant when Administered Alone and in Combination with Carbamazepine in Healthy Post-Menopausal Female Participants

Trial Identifier: D8532C00006
Sponsor: AstraZeneca
Start Date: August 2024
Primary Completion Date: July 2025
Study Completion Date: July 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GB Harrow, GB, HA1 3UJ